Opendata, web and dolomites


Functional analysis of the kinome and phosphatome as determinants of integrin phosphorylation in cancer

Total Cost €


EC-Contrib. €






Project "INTEGRIN REGULATION" data sheet

The following table provides information about the project.


Organization address
city: Turku
postcode: 20014

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Total cost 190˙680 €
 EC max contribution 190˙680 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2018
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2021-07-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TURUN YLIOPISTO FI (Turku) coordinator 190˙680.00


 Project objective

Integrins are key signalling molecules that mediate the complex relationship between cancer cells and their associated ECM; as such they have been implicated in every step of cancer progression. Their cytoplasmic domains are essential hubs for protein-protein interactions, where phosphorylation of key sites modulates integrin activity and oncogenic signalling. However, the regulators of integrin phosphorylation remain elusive. The proposed work will address the role of integrin beta1 in breast cancer epithelial and stromal cells, where increased expression and/or activity are correlated with poorer survival. To this end, the fellow has developed a Förster resonance energy transfer (FRET) biosensor for integrin beta1 phosphorylation, which will be applied in a kinome-/phosphatome-wide screen for regulatory kinases and/or phosphatases. This screening will be completmented with global mass spectrometry to identify phosphorylation-sensitive interactions with the integrin beta1 cytoplasmic domain. Out of these screens, the fellow will validate the identified kinases and/or phosphatases using three-dimensional functional assays, as well as standard biochemical approaches, in conjunction with live super-resolution imaging to pinpoint the subcellular localization of the interacting complex. The clinical relevance of the identified kinases and/or phosphatases will then be evaluated with immunohistochemistry staining of large breast cancer cohorts, along with functional validation using patient material from clinical collaborators. These aspects will provide an essential link from the mechanistic insights to improving patient outcomes from this work.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INTEGRIN REGULATION" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INTEGRIN REGULATION" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

GRAHAM (2018)

Concepts of Graph Theory Applied to the Human Microbiome

Read More  

EGeoCC (2019)

Ethnic geography and civil conflict

Read More  

CINEMA (2019)

Creating an Infrastructure for the Numerical Exploration of Metallurgical Alloys

Read More